All Content Outsourced Pharma

  1. Trinity Biotech Announces Collaboration With University At Buffalo To Commercialize Novel Biomarkers For Sjögren's Syndrome 3/18/2026

    Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced it has entered into a collaboration agreement with the University at Buffalo, New York (“UB”). The partnership focuses on advancing and commercializing a suite of proprietary biomarkers for the earlier and more accurate detection of Sjögren’s Syndrome, one of the most common but underdiagnosed autoimmune diseases.

  2. Abzena Recognized As A Market-Leading Antibody-Drug Conjugate CDMO In Frost & Sullivan Radar Report 3/18/2026

    Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, today announced it has been named a leader in the Frost Radar™ Report for Antibody Drug Conjugate Contract Development and Manufacturing Organizations.

  3. Integrated Quality, Regulatory, And Safety Services 3/18/2026

    A single-vendor model for quality, regulatory, and safety services provides consistent project management and cost-effective scalability. Hear how integrated solutions support market entry and growth.

  4. Taiwan Bio Partners With Terumo Blood And Cell Technologies To Advance Automated Treg Manufacturing On Quantum Flex 3/18/2026

    Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company and global leader in blood management solutions, has entered into a collaboration with Taiwan Bio Therapeutics Inc. (Taiwan Bio) to transition regulatory T-cell (Treg) manufacturing onto the automated Quantum Flex platform, supporting a move from manual processes toward more scalable, repeatable production.

  5. Viral Vector Manufacturing (VVMF) Enters Into Licensing Agreement With OXB, Gaining Access To The OXB AAV And LV Viral Vector Platforms 3/18/2026

    Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first commercial viral vector Contract Development and Manufacturing Organisation (CDMO), today announces that it has entered into a licensing and option agreement with OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO.

  6. Celltrion Signs Supply Agreement With A Global Biopharma Worth Up To KRW 375.4 Billion, Reflecting Recognition Of Product Quality And Manufacturing Productivity, And Accelerating CDMO Growth 3/17/2026

    Celltrion announced today that it has signed a contract manufacturing (CMO) agreement with a global pharmaceutical company for the supply of drug substance. The counterparty remains undisclosed to ensure business confidentiality.

  7. Continuous Manufacturing For API Breakthroughs 3/17/2026

    Observe how a compound library, designed for chemical diversity and lead-like properties, uses advanced filtering to improve hit discovery, speed hit-to-lead development, and boost early-stage small molecule drug discovery.

  8. CEO Insights And Trends: The Future Of The Sterile Filling CDMO Industry 3/17/2026

    Denis Johnson, CEO, explores developments in the CDMO sector and reveals how GRAM is gearing up for its latest phase of growth in sterile filling.

  9. Bioprocess Training And Education 3/17/2026

    Advance from development to manufacturing with expert-led, hands-on, or virtual courses that strengthen process understanding and scale-up skills designed to support every stage of your molecule’s journey.

  10. Continuous Flow — An Emerging Alternative 3/17/2026

    Gain insights on transitioning from batch to continuous flow processes, the benefits of continuous flow chemistry, and ensuring regulatory compliance with Quality by Design (QbD) principles.